HH BIOTECHNOLOGY HOLDINGS CO: key financial figures for fiscal year 2015 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2015)

$8.0M

Net Income/Loss (FY2015)

$2.4M

Total Assets (FY2015)

$46.5M

Total Equity (FY2015)

$28.4M

Cash Flows from Operating Activities (FY2015)

$3.6M

Source: HH BIOTECHNOLOGY HOLDINGS CO 10-K filing (FY2015). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.